Note: this is less than one half of one percent of total Medicare spending.
It’s important to point out how vast this spending is so that headlines that give dollar figures are balanced and the hyperbolic rhetoric can be put in context.
I would point out that it may end up costing more to source and administer generic drugs than $3.6B and could end up harming the pharmaceutical research economy.